J. M. Andrews

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

R. Wise, J. M. Andrews, Laura Edwards · Antimicrobial Agents and Chemotherapy · 1983 · 480 citations · Full text

Antimicrobial Chemotherapy, Pharmaceutical Chemistry, Drug Resistance +17

Azithromycin concentrations at the sites of pulmonary infection

Robert A. Wise, J. M. Andrews, J. P. Ashby et al. · European Respiratory Journal · 1990 · 196 citations

Antibiotics, Lung Inflammation, Bronchial Mucosa +13

Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy

Ashish Soman, D. Honeybourne, J. M. Andrews et al. · Journal of Antimicrobial Chemotherapy · 1999 · 155 citations · Full text

The in-vitro activity of linezolid (U-100766) and tentative breakpoints

Robert A. Wise, J. M. Andrews, F. J. Boswell et al. · Journal of Antimicrobial Chemotherapy · 1998 · 151 citations · Full text

Tentative Breakpoints, Antiparasitic Agent, Antimicrobial Chemotherapy +17

A reassessment of the in-vitro activity of colistin sulphomethate sodium

C. Catchpole, J. M. Andrews, N. Brenwald et al. · Journal of Antimicrobial Chemotherapy · 1997 · 138 citations · Full text

Escherichia Coli, Antibiotic Resistance, Drug Resistance +16